Team Health Holdings Now Covered by Analysts at Robert W. Baird (TMH)
Investment analysts at Robert W. Baird started coverage on shares of Team Health Holdings (NYSE:TMH) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.
In other Team Health Holdings news, Chairman H. Lynn Massingale unloaded 15,000 shares of the company’s stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $49.96, for a total value of $749,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Team Health Holdings (NYSE:TMH) traded up 0.92% during mid-day trading on Wednesday, hitting $50.26. The stock had a trading volume of 655,893 shares. Team Health Holdings has a 52-week low of $36.41 and a 52-week high of $52.18. The stock has a 50-day moving average of $50.12 and a 200-day moving average of $46.78. The company has a market cap of $3.530 billion and a price-to-earnings ratio of 38.04.
Team Health Holdings (NYSE:TMH) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.04. The company had revenue of $641.65 million for the quarter, compared to the consensus estimate of $646.83 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. Analysts expect that Team Health Holdings will post $2.19 EPS for the current fiscal year.
A number of other firms have also recently commented on TMH. Analysts at Stifel Nicolaus raised their price target on shares of Team Health Holdings from $52.00 to $56.00 in a research note on Thursday, July 3rd. They now have a “buy” rating on the stock. Separately, analysts at Goldman Sachs downgraded shares of Team Health Holdings from a “conviction-buy” rating to a “buy” rating in a research note on Monday, June 16th. Finally, analysts at Deutsche Bank downgraded shares of Team Health Holdings from a “buy” rating to a “hold” rating in a research note on Friday, June 6th. They now have a $53.00 price target on the stock. They noted that the move was a valuation call. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $54.00.
Team Health Holdings, Inc is a supplier of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the United States, based upon revenues, patient visits, and number of clients.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.